from Breakingviews:

Pharma Arbageddon fears keep traders on sidelines

April 27, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from Breakingviews:

$12.8 bln prescription may clear up pharmacy M&A

March 30, 2015

UnitedHealth Chief Executive Officer Hemsley takes part in a panel discussion titled "Getting From Care to Cure" at the Milken Institute Global Conference in Beverly Hills,

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from Breakingviews:

Valeant’s $11 bln bid may have scored two knockouts

March 16, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

AbbVie CEO may have overpaid again in $21 bln deal

March 5, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Actavis sale dresses up barely investment grade

March 4, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Deal junkie Valeant shoots up on $10 bln fix

February 23, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from India Insight:

India needs 10-15 years to roll out universal health plan: KPMG

February 13, 2015

India will struggle to become a global superpower without an efficient healthcare system, and would need 10 to 15 years to cover everyone under its ambitious universal health coverage programme, KPMG's global health chief said.

from Breakingviews:

Drugmakers unlikely candidates for next big short

February 11, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer’s generics injection lifts mood for breakup

February 5, 2015

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pharma’s dying assets lack M&A remedy

December 5, 2014

By Neil Unmack

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.